Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase
US6489476B1 · kind B1 · utility
115Cited by
9References
165Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 3, 1999 |
| Grant date | Dec 3, 2002 |
| Priority date | — |
| Expiry date | Sep 3, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65846
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
FBPase inhibitors of the formula I and X are useful in the treatment of diabetes and other conditions associated with elevated blood glucose or excess glycogen storage.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.